Tectonic Therapeutic (TECX) Other Working Capital Changes (2017 - 2026)
Tectonic Therapeutic (TECX) reported Other Working Capital Changes of -$147000.0 for Q1 2026, up 93.38% year-over-year from -$76015.6 in Q1 2025, and up 84.39% quarter-over-quarter from -$942000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Other Working Capital Changes data on file, last reported at -$147000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$147000.0, up 93.38% year-over-year; the trailing twelve-month figure through Mar 2026 was -$570000.0 (up 77.17% YoY), and the FY2025 annual result was -$2.6 million, down 367.96% from the prior year.
- Other Working Capital Changes advanced to -$147000.0 in Q1 2026 per TECX's latest filing, from -$942000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.7 million in Q2 2023 and troughed at -$2.2 million in Q1 2025.
- A 5-year average of -$139470.6 and a median of -$147000.0 in 2026 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 26760.0% in 2023 and fell as far as 19781.82% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at -$229000.0 in 2022, then jumped by 824.45% to $1.7 million in 2023, then tumbled by 199.16% to -$1.6 million in 2024, then jumped by 42.74% to -$942000.0 in 2025, then surged by 84.39% to -$147000.0 in 2026.
- Business Quant data shows TECX's Other Working Capital Changes at -$147000.0 in Q1 2026, -$942000.0 in Q4 2025, and -$581000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -147,000.00 |
| Mar 31, 2026 | -147,000.00 |
| Dec 31, 2025 | -942,000.00 |
| Dec 31, 2025 | -942,000.00 |
| Sep 30, 2025 | -581,000.00 |
| Sep 30, 2025 | -581,000.00 |
| Jun 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | -2.22 Mn |
| Mar 31, 2025 | -2.22 Mn |
| Dec 31, 2024 | -1.65 Mn |
| Dec 31, 2024 | -1.65 Mn |
| Sep 30, 2024 | 828,000.00 |
| Sep 30, 2024 | 828,000.00 |
| Jun 30, 2024 | 541,000.00 |
| Jun 30, 2024 | 541,000.00 |
| Mar 31, 2024 | -289,000.00 |
| Mar 31, 2024 | -289,000.00 |
| Dec 31, 2023 | 1.66 Mn |
| Dec 31, 2023 | 1.66 Mn |